Extracellular Matrix Market Size, Trends and Growth Analysis by 2027

The worldwide extracellular matrix market is projected to grow from US$ 24.30 million in 2018 to US$ 47.46 million by 2027, reflecting a compound annual growth rate (CAGR) of 8.2% from 2019 to 2027.

Several factors are propelling the growth of the extracellular matrix market, including a notable rise in the prevalence of trauma and cardiovascular diseases, an increase in vascular reconstruction procedures, and a surge in new product launches. Despite these growth drivers, the challenges associated with the use of decellularized extracellular matrix present significant hurdles for market expansion.
The escalating rates of orthopedic trauma and cardiovascular conditions are among the primary contributors to market growth. The extracellular matrix plays a crucial role in the treatment of various chronic injuries resulting from surgeries, accidents, and long-term illnesses.

Chronic illnesses such as cancer, heart disease, and musculoskeletal disorders are leading causes of mortality and disability worldwide. There is a growing demand for advanced medical treatments and minimally invasive procedures that yield effective results in shorter timeframes. The extracellular matrix addresses this patient need effectively. However, the advanced nature of these procedures often incurs higher healthcare costs. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases account for approximately US$ 3.3 trillion in annual healthcare expenditures. Consequently, these increased costs are anticipated to further stimulate market growth and enhance service delivery.

Moreover, surgical orthopedic treatments, including joint arthroscopy, fracture repair, and general repairs of damaged muscles or tendons, often necessitate the use of extracellular matrix. These injuries frequently arise from sports activities and road accidents. For example, data from the National Safety Council indicates that in 2015, individuals aged 5 to 14 represented 51% of all football-related injuries treated in emergency departments across the United States. Therefore, the factors outlined above are expected to significantly boost the market during the forecast period.

The global extracellular matrix market is categorized based on application and raw material. In terms of application, the market is divided into vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair, and soft tissue repair. When considering raw materials, the market is segmented into bovine, porcine, and other sources. Among the various applications, the soft tissue repair segment commands the largest market share, while the porcine segment leads in terms of raw material usage.

The report on the extracellular matrix market incorporates insights from a variety of primary and secondary sources, including the World Health Organization, the Arthroscopy and Sports Medicine Society, the American Society of Orthopedic Surgeons, the American Society of Plastic Surgeons, the Biological Sciences Research Council, the Center for Commercialization of Regenerative Medicine, the Centers for Disease Control and Prevention, the Engineering and Physical Sciences Research Council, the International Society of Aesthetic Plastic Surgery, and the Natural Sciences and Engineering Research Council of Canada, among others.